13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001104659-23-021612
Total Value
$162.5M
Positions
34
Other Managers
0
Confidential Omitted
No
Holdings (34)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $19.6M | 12.08% |
| 2 | VIRIDIAN THERAPEUTICS INC | VRDN | 396,500 | $11.6M | 7.13% |
| 3 | APELLIS PHARMACEUTICALS INC | APLS | 217,500 | $11.2M | 6.92% |
| 4 | TERNS PHARMACEUTICALS INC | TERN | 1,100,000 | $11.2M | 6.89% |
| 5 | UNITED THERAPEUTICS CORP DEL | UTHR | 33,000 | $9.2M | 5.65% |
| 6 | SAREPTA TEHRAPEUTICS INC | SRPT | 67,500 | $8.7M | 5.38% |
| 7 | SYNDAX PHARMACEUTICALS INC | SNDX | 324,614 | $8.3M | 5.08% |
| 8 | IVERIC BIO INC | 46583P102 | 360,500 | $7.7M | 4.75% |
| 9 | VENTYX BIOSCIENCES INC | 92332V107 | 290,500 | $7.6M | 4.65% |
| 10 | VAXCYTE INC | PCVX | 144,500 | $6.9M | 4.26% |
| 11 | CYMABAY THERAPEUTICS INC. COMMON STOCK | 23257D103 | 1,015,000 | $6.4M | 3.92% |
| 12 | KURA ONCOLOGY INC. COMMON STOCK | KURA | 501,500 | $6.2M | 3.83% |
| 13 | MERSANA THERAPEUTICS INC | 59045L106 | 950,000 | $5.6M | 3.43% |
| 14 | BELLUS HEALTH INC | 07987C204 | 632,500 | $5.2M | 3.20% |
| 15 | CELLDEX THERAPEUTICS INC | CLDX | 115,000 | $5.1M | 3.15% |
| 16 | ROCKET PHARMACEUTICALS INC | RCKTW | 260,000 | $5.1M | 3.13% |
| 17 | BIOATLA INC | BCAB | 500,000 | $4.1M | 2.54% |
| 18 | ACLARIS THERAPEUTICS | ACRS | 255,000 | $4.0M | 2.47% |
| 19 | KEROS THERAPEUTICS INC | KROS | 80,000 | $3.8M | 2.36% |
| 20 | GH RESEARCH PLC | GHRS | 243,250 | $2.4M | 1.45% |
| 21 | ARGEN SE | ARGX | 5,100 | $1.9M | 1.19% |
| 22 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 41,029 | $1.7M | 1.02% |
| 23 | FULCRUM THERAPEUTICS INC | FULC | 185,000 | $1.3M | 0.83% |
| 24 | PMV PHARMACEUTICALS INC | PMVP | 154,471 | $1.3M | 0.83% |
| 25 | EYEPOINT PHARMACEUTICALS INC | EYPT | 303,396 | $1.1M | 0.65% |
| 26 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 153,639 | $981,753 | 0.60% |
| 27 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 93,500 | $981,750 | 0.60% |
| 28 | PYXIS ONCOLOGY INC | PYXS | 669,158 | $896,672 | 0.55% |
| 29 | REZOLUTE INC | RZLT | 420,000 | $869,400 | 0.54% |
| 30 | HORIZON THERAPEUTICS PLC | G46188101 | 6,000 | $682,800 | 0.42% |
| 31 | PROTHENA CORPORATION PLC | PRTA | 9,300 | $560,325 | 0.34% |
| 32 | IMARA INC | 45249V107 | 44,503 | $182,017 | 0.11% |
| 33 | KINNATE BIOPHARMA INC | 49705R105 | 5,000 | $30,500 | 0.02% |
| 34 | NUVATION BIO INC | NUVB | 90,832 | $13,125 | 0.01% |